Previous close | 1,002.95 |
Open | 998.45 |
Bid | 1,001.53 x 100 |
Ask | 1,002.67 x 100 |
Day's range | 992.22 - 1,002.95 |
52-week range | 684.81 - 1,016.00 |
Volume | |
Avg. volume | 440,503 |
Market cap | 110.377B |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | 29.55 |
EPS (TTM) | 33.90 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1,061.30 |
Regeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market usually pay for a...
Several stocks are breaking out and trading near all-time highs.
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is the best bet in the gene therapy sector. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]